CDK2 overexpression
|
Estrogen Receptor Positive Breast Cancer
|
CDK2 overexpression
|
Estrogen Receptor Positive Breast Cancer
|
palbociclib Resistant: C3 – Early Trials
|
palbociclib Resistant: C3 – Early Trials
|
CDK2 overexpression
|
Adrenal Cortex Carcinoma
|
CDK2 overexpression
|
Adrenal Cortex Carcinoma
|
DSP-2033 Sensitive: D – Preclinical
|
DSP-2033 Sensitive: D – Preclinical
|